Regulatory Filings • Nov 5, 2020
Regulatory Filings
Open in ViewerOpens in native device viewer
Current report №125/ 2020 Dated November 5, 2020
Sopharma AD notifies that for October 2020 the Company recorded a decrease in sales of 38% compared to the same month of 2019, incl. 40% decrease in domestic sales and 37% decrease in export sales.
In the first ten months of 2020 the revenues from sales of production decrease by 15% compared to the same period of 2019, incl. 21% decrease of sales for the domestic market and 11% decrease in export sales.
Signatures of individuals authorized to represent the Company:
Ognian Donev
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.